299660.KQ
Cellid, Co., Ltd.
KOE · Healthcare · Medical - Pharmaceuticals · KR
KRW 2,405.00
−1.03%Margins
Gross margin
5.1%
EBITDA margin
-83.2%
EBIT margin
-104.5%
Net margin
-262.8%
FCF margin
-251.7%
-51.0%
Return on equity
-28.3%
Return on assets
-12.5%
Return on invested capital
0.10x
Asset turnover
-KRW 12.2B
Cash from operations
KRW 572
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026